Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.
about
Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complexAn economic analysis of premarriage prevention of hepatitis B transmission in IranSelf-assembling protein nanoparticles in the design of vaccinesHepatitis B and A vaccination in HIV-infected adults: A reviewOld and new: recent innovations in vaccine biology and skin T cellsImpaired Antigen-Specific Immune Response to Vaccines in Children with Antibody Production DefectsImmune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccineFive years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study.Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccinationAlternative dosage schedules with HPV virus-like particle vaccines.Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.Seroprevalence and risk factors for hepatitis B infection in an adult population in Northeast China.Randomized trial of the immunogenicity and safety of the Hepatitis B vaccine given in an accelerated schedule coadministered with the human papillomavirus type 16/18 AS04-adjuvanted cervical cancer vaccineThe evaluation of Tetanus-diphtheria (Td) vaccine impacts on immune response to hepatitis B (HB) vaccine in non-responder dialysis patientsHuman immunodeficiency virus vaccinesSafety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adultsComparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults.A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge.CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated Chimpanzees.Hepatitis-B vaccination status among dental surgeons in benin city, Nigeria.Rapid immunization scheme for spouses of individuals estabilished as hepatitis B carriers during premarital tests.Suitable hepatitis B vaccine for adult immunization in China.A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing.Economic evaluation of delivering hepatitis B vaccine to injection drug usersVaccine-Induced Anti-HBs Level in 5-6 Year-Old Malnourished Children.Plant-derived virus-like particles as vaccinesProspective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus.Antibody to Hepatitis B Surface Antigen in Vaccinated Health Care Workers.Protective anti-hepatitis B virus responses in rhesus monkeys primed with a vectored measles virus and boosted with a single dose of hepatitis B surface antigen.Influenza virus-like particle vaccines.Memory T cells specific for HBV enumerated by a peptide-based cultured enzyme-linked immunospot assay in healthy HBV-vaccinated subjects.A review of multiple approaches towards an improved hepatitis B vaccine.The Emergent Concern of Hepatitis B globally with special attention to Kingdom of Saudi Arabia.Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg- mothers.Swine influenza vaccines: current status and future perspectives.Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities.The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: the evidence, current practice and future challenges.Advances and applications of molecular cloning in clinical microbiology.Antigen delivery by virus-like particles for immunotherapeutic vaccination.
P2860
Q21089588-EED44168-F246-43A2-A69F-0680DD84E62FQ24792372-4AA2B0A5-6346-4A38-9ED2-01AE48D5CBF0Q26767097-9E2E2021-E44C-4DAB-819D-D65EB479DBD4Q26799782-7263FCD1-35AC-4A64-82D7-9D421D3D6E67Q27013570-ED894626-D697-4DB1-A7CB-B60211B3B8F7Q28384666-AC616D0B-D1A4-4B01-A5CE-6DDAA6F39B49Q33577990-C2F5FADA-4E13-4BB7-BE78-B619D6D447DBQ33776106-BE822C73-7AED-4865-AA7A-F5C6E1D9A48CQ33820427-4C87253E-37A4-40C6-AE73-39F3DBEB1FE4Q34102466-1FC582F0-C12C-43A0-9803-6D899FE91F4FQ34621859-138255D8-0453-4A5D-AF29-E1ADD09C4C87Q35001822-B52C76EE-85D3-4373-B21E-DD5E667DC402Q35191198-B4A86C1B-8085-4F3F-86A6-CFEFDCF442D1Q35544859-556071CF-9FD6-47DC-98D7-54B5E16E3C94Q35674731-E661A495-5010-426B-ADD2-B9C73F48BC4FQ35878625-0DB6B71C-D760-41EC-B837-3369F7D6AE4CQ35887572-80CCF780-C626-483A-8F88-E0042499C81FQ36099144-AC7F3D81-542B-49B2-A3B5-60C281043F80Q36365279-3C3150CE-CB40-4FFD-B655-F67F47E0A75BQ36425374-6FA81379-72EF-4EFD-86B1-227B0E2576CCQ36490608-EC4148C7-59F1-45BB-B65F-3EB6259368B8Q36501783-9F548142-04E2-49BB-94DE-B139238BB30AQ36711264-EFFDCDE0-F821-4072-817C-4E3CE8C00BF7Q36789998-8F31D3D9-239A-4903-AFD7-D9237FDB8CB7Q36816598-EA483E4C-B917-4BD2-9BF9-7CF3CEF3924EQ36888029-7892AB21-82C1-476C-89A2-11DB96C56307Q37197093-AB93279A-6890-4A30-995C-4517C87EB6C4Q37280298-78238B6E-D740-4D32-9A76-52ED8E8EDEDEQ37333844-1A0B9F42-8B4A-470F-B309-6A1AFB6963E1Q37434529-C89872AA-1EC6-4945-9B64-C6529587729AQ37473274-76D6E1E5-7B69-4006-8587-6B500BCED3F9Q37481243-708D2919-D659-476A-92A7-3966A27310C8Q37577719-6F33EEF2-7653-4F5C-BEF5-7FA0750D6562Q37729188-7B47FF99-AD20-47FF-886A-06F8A7A339D4Q37749889-1FD95937-8271-49EA-B19F-6D311602E755Q37997825-64D1A97F-EB79-4648-84B3-2F300D25F71BQ38111651-519A0C9F-FD73-4B8E-970D-E4761AC8B328Q38211738-63241FDE-7257-41F8-A25E-4A1EAC59F80CQ38229428-22135A8F-18FF-41AD-B031-62E8BDCAD5E2Q38285854-9F9E9B9F-ACEF-47DF-9176-287B43F770A4
P2860
Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Recombinant hepatitis B vaccin ...... efficacy against hepatitis B.
@ast
Recombinant hepatitis B vaccin ...... efficacy against hepatitis B.
@en
type
label
Recombinant hepatitis B vaccin ...... efficacy against hepatitis B.
@ast
Recombinant hepatitis B vaccin ...... efficacy against hepatitis B.
@en
prefLabel
Recombinant hepatitis B vaccin ...... efficacy against hepatitis B.
@ast
Recombinant hepatitis B vaccin ...... efficacy against hepatitis B.
@en
P1433
P1476
Recombinant hepatitis B vaccin ...... efficacy against hepatitis B.
@en
P2093
Stuart Noble
P304
P356
10.2165/00003495-200363100-00006
P577
2003-01-01T00:00:00Z
P6179
1001993733